Skip to main content
Clinical trial of a new vaccine against Rotavirus in Maradi / Niger

Innovative vaccine against rotavirus

War in Gaza:: find out how we're responding
Learn more

This slideshow explains the challenges posed by rotavirus and the existing constraints of the existing vaccines. It shows the story of the Epicentre study in Maradi district, Niger. The vaccine is now proven safe and effective. Last step: prequalification by the World Health Organization (WHO).

Up Next
Press Release 23 March 2017